Centering(patientswith)fibroids - uterine fibroids (UF), smooth muscle neoplasms of the myometrium, affect nearly 80% of women before age 50 years and impact the lives of 26 million women in the…

Ended Project Grant Awarded Last action

Award ID
ASTWH220118
Recipient
Awarding agency
Obligated
$1,887,347

Award facts

Completion date
Originally
Funding agency
Office of the Assistant Secretary for Health Department of Health and Human Services
Place of performance
Massachusetts, USA

Award details come from USAspending.gov.

Description

Centering(patientswith)fibroids - uterine fibroids (UF), smooth muscle neoplasms of the myometrium, affect nearly 80% of women before age 50 years and impact the lives of 26 million women in the united states alone. Non-hispanic black women, experience 2-3 times the incidence of UF, earlier onset of disease, and greater disease severity (larger tumor size, more numerous tumors, and heavier bleeding) than non-hispanic white women.[1] symptomatic UF dramatically reduce quality of life, causing severe bleeding, anemia, pain, infertility, and complications of pregnancy and delivery. Uterine fibroids remain the primary indication for hysterectomy in the united states. At boston medical center (BMC), clinicians in the OB/GYN department see hundreds of patients and perform at least 200 UF-related surgeries each year. BMC is the largest safety-net hospital in new england, with over 70% of the patient population coming from underserved communities. Over two-thirds of BMC's population identify as black - a population shown to experience the highest UF burden. Beyond this disproportionate burden of disease among black women, evidence also shows that implicit racial bias within the healthcare system has been directly linked to delivery of lower quality care for patients of color.[2] IT was with this health inequity in mind that the centering(patientswith)fibroids (cpwf) intervention was developed. Adapted from the centering healthcare institute's model of group care, our program prioritizes a multidisciplinary, patient-centered, and evidence-based approach to patient care for women diagnosed with UF.[3] more specifically, the cpwf intervention was designed to engage and empower patient participants, with the end goal of improving patient knowledge, understanding of their health condition, and available treatment options. With this approach, patients' mistrust of the healthcare system will be understood and addressed, thereby improving outpatient healthcare resources, and improving patient outcomes.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $269,621
Amendment $269,621
Amendment $0
Amendment $0
Amendment $0
Amendment $269,621
Amendment $269,621
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $269,621
Amendment $269,621
Original award $269,621
Show all 20

Subawards

Subrecipient Amount Awarded
Emory University Centering (patients with) Fibroids - OWH Proposal $51,718
Yale Univ $25,674
Emory University 1. Reviewing the proposed Fibroid Center plan / curriculum and reaching an agreement on the content of the program. 2. During and after implementation, Dr. Hill… $37,200

Quick answers

Who received award ASTWH220118?

ASTWH220118 was awarded to Boston Medical Center Corporation by Office of Grants Management (Office of the Assistant Secretary for Health) on September 30, 2022.

How much is award ASTWH220118 worth?

$1,887,347 has been obligated on ASTWH220118.

Which agency awarded ASTWH220118?

Office of Grants Management (Office of the Assistant Secretary for Health) awarded ASTWH220118, with funding from Office of the Assistant Secretary for Health (Department of Health and Human Services).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award